Saronic Biotechnology is a New York City-based company founded by physicians and research scientists specializing in oncology, viral hepatitis, and immunology. They are dedicated to developing innovative immunotherapies for liver cancer, utilizing the latest technologies to create highly effective treatments.
Their flagship product, SBI1997, is a cellular immunotherapy designed to prevent cancer recurrence by priming the immune system to identify and eliminate tumor-specific cancer cells. Saronic Biotechnology is committed to revolutionizing liver cancer treatment and changing the future of patients with hepatocellular carcinoma (HCC).
Generated from the website